Memorial Healthcare System Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01333488
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Memorial Healthcare System

Active Ingredients

Drugs in Phase 4 Trials (2)

alteplase (Activase) (1 trial)

talc (sclerosol) (1 trial)

Drugs in Phase 2 Trials (1)

magnesium sulfate (Tis-U-Sol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Hypothermia (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3